Charged Peptide Tag for Oriented Protein Immobilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for immobilizing proteins, such as antibodies and enzymes, on surfaces often result in random orientation, which can impair their activity due to the limited control over the positioning of carboxyl and amine residues, making it challenging to preserve maximal activity during covalent surface immobilization.
Innovation Solution
A fusion protein with a positively-charged domain is genetically appended to the N-terminus or C-terminus of the polypeptide, allowing for directional immobilization and chemical attachment of molecules like biotin or dyes, ensuring the active site remains unobstructed and enhancing protein activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If covalent surface immobilization using carbodiimide or succinimide ester chemistry is used, then protein attachment to surface is achieved, but random orientation occurs reducing protein activity
Solution Approach 1:
The invention introduces a charged peptide tag (either positively charged with multiple lysines or negatively charged with multiple glutamates) at a specific location (N- or C-terminus) of the protein. This localized charge distribution creates a directional electrostatic interaction with the oppositely charged surface, ensuring that the protein orients in a specific direction during immobilization. The active site remains unobstructed while achieving controlled orientation, resolving the contradiction between random attachment and oriented immobilization.
Solution Approach 2:
The charged peptide tag acts as an intermediary element between the protein and the charged surface. Instead of the protein directly interacting with the surface through its various surface residues (which leads to random orientation), the charged tag mediates the interaction by providing a concentrated charge that directs the orientation. This intermediary layer enables controlled electrostatic attachment while preserving the protein's active conformation.
2Reliability
If natural proteins are used for immobilization, then protein function is maintained, but limited orientation control is available
Solution Approach 1:
The invention creates a composite structure by fusing a charged peptide tag (synthetic element) to the natural protein sequence. This composite fusion protein combines the functional properties of the natural protein with the directional charging properties of the peptide tag. The tag contains multiple identical charged residues (lysines or glutamates) that create a strong electrostatic field for oriented attachment, while the rest of the protein maintains its natural function.
3Measurement precision
If small recombinant antibody derivatives are used, then assay sensitivity is improved, but fewer random attachment sites are available increasing orientation difficulty
Solution Approach 1:
For small recombinant antibody derivatives where every attachment site is critical, the invention places a charged peptide tag at the terminus of the antibody. This localized charge concentration ensures that electrostatic attachment occurs through the tag rather than through distributed surface residues, providing precise orientation control. The tag's position at the N- or C-terminus ensures that the antigen-binding sites remain unobstructed while achieving directional immobilization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a significant increase in active protein immobilization, enhancing detection sensitivity by 4-fold or more, as demonstrated with single-domain antibodies in various assays, including surface plasmon resonance and fluorimmunoassays, while maintaining recombinant production efficiency.
Implementation Method 1
a positively-charged domain with at least 85% sequence identity to SEQ ID No: 1 or SEQ ID No: 2 fused to the N-terminus or C-terminus of the polypeptide
Data Source
AI summary
Genetic fusions of proteins, for example single-domain antibodies (sdAbs), with a positively-charged domain enhanced immobilization of active protein in a desired orientation.